{"DataElement":{"publicId":"5229059","version":"1","preferredName":"Kidney Cancer American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Distant Metastasis M Stage","preferredDefinition":"Extent of the distant metastasis for the kidney carcinoma based on evidence obtained from pathologic examination through completion of definitive surgery.","longName":"5228356v1.0:5229040v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"5228356","version":"1","preferredName":"Kidney Carcinoma Pathologic M Stage","preferredDefinition":"A carcinoma arising from the epithelium of the renal parenchyma or the renal pelvis.  The majority are renal cell carcinomas.  Kidney carcinomas usually affect middle aged and elderly adults.  Hematuria, abdominal pain, and a palpable mass are common symptoms._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system.  M refers to the presence of metastasis.","longName":"3201550v1.0:2207807v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3201550","version":"1","preferredName":"Renal Carcinoma","preferredDefinition":"A carcinoma arising from the epithelium of the renal parenchyma (renal cell carcinoma) or the renal pelvis (renal pelvis carcinoma).  The vast majority of renal cell carcinomas are adenocarcinomas.  The vast majority of renal pelvis carcinomas are transit","longName":"C9384","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kidney Carcinoma","conceptCode":"C9384","definition":"A carcinoma arising from the epithelium of the renal parenchyma or the renal pelvis.  The majority are renal cell carcinomas.  Kidney carcinomas usually affect middle aged and elderly adults.  Hematuria, abdominal pain, and a palpable mass are common symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E241B3C-89F4-11DA-E040-BB89AD437FA3","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-10","modifiedBy":"ONEDATA","dateModified":"2011-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207807","version":"1","preferredName":"Pathologic M Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system.  M refers to the presence of metastasis.","longName":"C25610:C25727","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-30F5-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC:American Joint Committee on Cancer Cancer Staging Manual, 7th Ed., 2009","workflowStatus":"RELEASED","registrationStatus":"Application","id":"30EC517F-D9A5-AFBE-E050-BB89AD43662A","latestVersionIndicator":"Yes","beginDate":"2016-04-20","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-04-20","modifiedBy":"HARTLEYG","dateModified":"2016-07-26","changeDescription":"Created for BBRB per request by G.Deen. mc 4/20/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5229040","version":"1","preferredName":"Kidney Cancer Pathologic Distant Metastasis TNM Finding v7 American Joint Committee on Cancer Stage","preferredDefinition":"A pathologic finding about one or more characteristics of kidney cancer, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases.  There is no pathologic M0 for kidney cancer. (from AJCC 7th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"5229040v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"M1","valueDescription":"Kidney Cancer pM1 TNM Finding","ValueMeaning":{"publicId":"5229042","version":"1","preferredName":"Kidney Cancer pM1 TNM Finding","longName":"5229042","preferredDefinition":"Kidney cancer with distant metastasis. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kidney Cancer pM1 TNM Finding v6 and v7","conceptCode":"C63577","definition":"Kidney cancer with distant metastasis. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30FE35F1-4B9F-A3ED-E050-BB89AD433C92","latestVersionIndicator":"Yes","beginDate":"2016-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"30FE35F1-4BB8-A3ED-E050-BB89AD433C92","beginDate":"2016-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-21","modifiedBy":"ONEDATA","dateModified":"2016-04-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5229039","version":"1","preferredName":"Kidney Cancer Pathologic Distant Metastasis TNM Finding v7 American Joint Committee on Cancer Stage","preferredDefinition":"A pathologic finding about one or more characteristics of kidney cancer, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases.  There is no pathologic M0 for kidney cancer. (from AJCC 7th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C89296:C39315:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kidney Cancer Pathologic Distant Metastasis TNM Finding v7","conceptCode":"C89296","definition":"A pathologic finding about one or more characteristics of kidney cancer, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases.  There is no pathologic M0 for kidney cancer. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30FE35F1-4B73-A3ED-E050-BB89AD433C92","latestVersionIndicator":"Yes","beginDate":"2016-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-21","modifiedBy":"ONEDATA","dateModified":"2016-04-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"30FE35F1-4B84-A3ED-E050-BB89AD433C92","latestVersionIndicator":"Yes","beginDate":"2016-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-21","modifiedBy":"HARTLEYG","dateModified":"2016-07-26","changeDescription":"Created for BBRB as requested by G.Deen. mc 4/21/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"5228272","version":"1","longName":"Kidney","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5188870","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB","ClassificationSchemeItems":[{"publicId":"5405791","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB"},{"publicId":"6736423","version":"1","longName":"Kidney Local Path Review","context":"BBRB"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"10000432","version":"1","longName":"Kidney","context":"NCI Standards"}]}],"AlternateNames":[{"name":"BBRB","type":"USED_BY","context":"BBRB"}],"ReferenceDocuments":[{"name":"Pathologic M Stage","type":"Preferred Question Text","description":"Pathologic M Stage","url":null,"context":"NCI Standards"},{"name":"BPV_GTEx","type":"BBRB Text","description":"M: Distant Metastases (AJCC 7th Edition)","url":null,"context":"BBRB"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"30FEE52A-EC17-91CB-E050-BB89AD4333ED","latestVersionIndicator":"Yes","beginDate":"2016-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-21","modifiedBy":"TAYLORT","dateModified":"2017-04-19","changeDescription":"Created for BBRB as requested by G. Deen. mc 4/21/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}